Related Experiment Video
Updated: Aug 25, 2026

MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells
Published on: December 21, 2011
RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma
Lillian Shuk-Nga Chow1, Kwok-Wai Lo, Joseph Kwong
1Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
Abstract:
Deletion on the short arm of chromosome 3 is one of the most important genetic abnormalities in the tumorigenesis of nasopharyngeal carcinoma (NPC). Both physical mapping and functional studies have targeted an NPC-related tumor suppressor gene(s) to chromosome 3p21.3. We have reported recently that RASSF1A gene, located on a 120-kb minimal deletion region on 3p21.3, was frequently inactivated by promoter hypermethylation in NPC. We further confirmed that RASSF1A is the critical target tumor suppressor from 3p21.3, with the evidence that loss of expression and aberrant methylation of the other 8 candidate genes/transcripts (HYAL2, FUS1, RASSF1C, BLU, NPRL2, 101F6, PL6 and CACNA2D2) in this 120-kb region were rare in NPC samples. The contribution of RASSF1A in NPC tumorigenesis was investigated by restoring its expression in a RASSF1A deficient cell line, C666-1. Transient transfection of wild-type RASSF1A resulted in marked growth inhibition in NPC cells. Isolated stable clones expressing wild-type RASSF1A demonstrated retarded cell proliferation in vitro. Soft-agar assay also showed decreased number and sizes of colony formed in these clones. In vivo nude mice assay demonstrated the dramatic reduction of tumorigenic potential in the RASSF1A-transfected clones. Our results provide strong evidence to support RASSF1A as a target tumor suppressor gene on 3p21.3 in NPC.
Insights
RASSF1A gene inactivation is crucial in nasopharyngeal carcinoma (NPC) development. Restoring RASSF1A expression significantly inhibits NPC cell growth and tumorigenesis, identifying it as a key tumor suppressor.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Chromosome 3p deletions are significant in nasopharyngeal carcinoma (NPC) tumorigenesis.
- The 3p21.3 region is a focus for identifying NPC-related tumor suppressor genes.
Purpose of the Study:
- To confirm RASSF1A as the critical tumor suppressor gene in the 3p21.3 region for NPC.
- To investigate the functional role of RASSF1A in NPC tumorigenesis.
Main Methods:
- Analysis of RASSF1A inactivation via promoter hypermethylation in NPC.
- Restoration of RASSF1A expression in a deficient NPC cell line (C666-1).
- In vitro assays (cell proliferation, soft-agar) and in vivo (nude mice) studies to assess tumorigenic potential.
Main Results:
- RASSF1A was frequently inactivated by promoter hypermethylation in NPC.
- Other candidate genes in the 120-kb deletion region showed rare inactivation.
- Restoring RASSF1A expression led to significant growth inhibition, reduced proliferation, and decreased colony formation in vitro.
- RASSF1A-transfected clones showed dramatically reduced tumorigenic potential in vivo.
Conclusions:
- RASSF1A is the critical target tumor suppressor gene on chromosome 3p21.3 in NPC.
- RASSF1A plays a significant role in inhibiting NPC cell growth and tumorigenesis.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...